Leerlingen.com Forum - Enkele bericht bekijken

Astrada · 28 June 2007, 15:23

Chrizzly, dit staat er op marktplaats en is dus een STRUCTUREEL probleem binnen de psychiatrie...

http://www.marktplaats.nl/index.php?...tml%3Fxref%3D1

En daar al mijn bronnen bij voorbaat al worden afgekraakt door Chrizzly en hij tevens weigerd ze via links te bekijken zet ik ze maar voor zijn neus neer op dit forum.

Dit is éénmalig, als poging om van de herhaaldelijke ontkenningen omtrent mijn bronnen door Chrizzly af te zijn, hoop niet dat het gezien word als forum-vervuiling...

2“Suicidality in Children and Adolescents Being Treated With Antidepressant Medications”, FDA Public Health Advisory, 15 Oct. 04.
3“New Warning for Strattera” FDA Talk Paper, 17 Dec. 04.
4“FDA Issues Public Health Advisory for Antipsychotic Drugs Used for Treatment of Behavioral Disorders in Elderly Patients,” FDA Talk Paper, 11 Apr. 05.
5“European Medicines Agency finalises review of antidepressants in children and adolescents,” European Medicines Agency Press Release, 25 Apr. 05.
6“Statement on Concerta and Methylphenidate”, Statement posted on the FDA website, 28 June 05.
7“Suicidality in Adults Being Treated with Antidepressant Medications,”FDA Public Health Advisory, 30 June 05.
8“Accompanying Statement by Joseph A. Califano, Jr., Cairman ans President”, Under the counter: The Diversion and Abuse of Controlled Prescription Drugs in the U.S, National Center on Addiction and Substance Abuse at Columbia University, July 05, pp.i-iii.
9Joanna Moncrief and Irving Kirsch, “Efficacy of Antidepressants in Adults”, British Medical Journal, Vol.331,16 July 05,pp. 155-157.
10“Accompanying Statement by Joseph A. Califano, Jr., Cairman and President,”National Survey of American Attitudes on Substance Abuse X: Teens and Parents, National Center on Addiction and Substance Abuse at Columbia University, Aug. 05, pp. I-ii.
11“Annex II,” Commission Decision of 19-VIII-2005, Commission of the European Communities, 19 Aug. 05.
12Ivar Aursnes, et al., “Suicide Attempts in Clinical Trials with Paroxetine Randomised Against Placebo”, BMC Medicine, Vol.3,pp. 14-18.
13Marian S. Macdonagh, PharmaD, and Kim Peterson, MS “Drug Class Review on Pharmacologic Treatment for ADHD: Final Report,”Oregon Health and Science University, Sept. 05, pp. 13-20.
14Jeffrey A. Lieberman, MD, et al.,“Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia,” New England Journal of Medicine, Vol.353, No. 12, 22 Sept. 05, pp. 1209-1232.
15Laurent Neergaard, “FDA Commissioner Lester Crawford Resigns,” Associated Press, 23 Sept. 05; Robert Pear and Andrew Pollack, “Leader of the FDA Steps Down After a Short Turbulent Tenure,” New York Times, 24 Sept. 05.
16“Depression in Children and Young People,” National Institute for Health and Clinical Excellence, Sept. 05, pp. 16,18 and 28.
17“Suicidal Thinking in Children and Adolescents Being Treated with Strattera (Atomoxetine),” FDA Public Health Advisory, 29 Sept. 05.
18“Concluding Observations (Australia)”, UN Committee on the Rights of the Child, 40th Session, 30 Sept. 05; “Comcluding Observations (Denmark)”, UN Committee on the Rights of the Child, 40th Session, 30 Sept. 05; “Comcluding Observations (Finland)”, UN Committee on the Rights of the Child, 40th Session, 30 Sept. 05.

Jeannie Russell, “The Pill That Teachers Push,” Good Housekeeping, Dec. 1997
“Survey: 1 in 5 Teens Getting High on Medications, Over-Counter Drugs,” NewsItem.com, 2 June 2005
Joyce Howard Price, “Antidepressant Use by Preschoolers Rising,” The Washington Times, 3 Apr. 2004
Jacqueline A. Sparks, Ph.D. & Barry L. Duncan, Psy.D., “The Ethics and Science of Medicating Children,” Center for Family Services, Palm Beach County & Florida Institute for the Study of Therapeutic Change
Jennifer Washburn, “Tainted to the Core: Why Conflicts of Interest are Hazardous to Your Health,” Institute for Public Affairs, In These Times, 20 June 2005
Fred Baughman Jr., M.D, “Transcript: Calls for Investigation into Diagnosis of ADHD,” ABC Australia Online, 23 Mar. 2000, Internet URL: http://www.abc.net.au; “The White House on Ritalin,” New York Press, 29 Mar. - 4 Apr. 2000
Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, “Psychopharmacologic Drugs Advisory Committee With the Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee,” Testimony of Dr. Gianna Rigoni from the Office of Drug Safety of the FDA, 2 Feb. 2004
Kate Zernike and Melody Petersen, “Schools’ Backing of Behavior Drugs Comes Under Fire,” The New York Times, 19 Aug. 2001
Karen Thomas, “Back to School for ADHD Drugs,” USA Today, 28 Aug. 2001
“Leading Therapy Classes by Global Pharmaceutical Sales, 2003,” IMSHealth.com, 2004
Op. cit., Karen Thomas
Dr. Tana Dineen, Ph.D., Manufacturing Victims, Third Edition, (Robert Davies Multimedia Publishing, Montreal, 2001), p. 86
“Ten Things That Drive Psychiatrists To Distraction,” The Independent, (United Kingdom), 19 Mar. 2001
Sydney Walker, III, M.D., A Dose of Sanity: Mind, Medicine and Misdiagnosis, (John Wiley & Sons, Inc, New York, 1996), p. 5
Thomas S. Szasz, M.D., The Therapeutic State, Psychiatry in the Mirror of Current Events, (Prometheus Books, New York, 1984), p. 32
David Kaiser, M.D., “Commentary: Against Biologic Psychiatry,” Psychiatric Times, Dec. 1996,
http://www.mhsource.com/edu/psytimes/p961242.html
Bruce D. Levine, Ph.D., Commonsense Rebellion: Debunking Psychiatry, Confronting Society, (Continuum, New York, 2001), p. 277
Elliot S. Valenstein, Ph.D., Blaming the Brain, (The Free Press, New York, 199

, p. 4
Joseph Glenmullen, M.D., Prozac Backlash, (Simon & Schuster, NY, 2000), pp. 193, 196
Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder, National Institutes of Health Consensus Statement Online, 16-18 Nov. 1998
“Anatomical MRI of the Developing Human Brain: What Have We Learned? Magnetic resonance imaging; Statistical Data Included. Journal of the American Academy of Child and Adolescent Psychiatry, 1 Sept. 2001
Lisa M. Krieger, “Some Question Value of Brain Scan; Untested Tool Belongs in Lab Only, Experts Say,” The MercuryNews, 4 May 2004
Ibid.
Ibid.
Kelly Patricia O’Meara, “In ADHD Studies, Pictures May Lie,” Insight on the News, 19 Aug, 2003
Elliot S. Valenstein, Ph.D., Blaming the Brain (The Free Press, New York, 199

, p. 126
Ibid.
Dr. Mary Ann Block, No More ADHD, (Block Books, Texas, 2001), p.30
“National Institutes of Health Consensus Development Conference: Diagnosis and Treatment of Attention-
Deficit/Hyperactivity Disorder,” Journal of the American Academy of Child and Adolescent Psychiatry, No. 2, Vol. 39, p. 182; Op. cit., Dr. Mary Ann Block, p. 53
Jan Strydom, Susan du Plessis, The Myth of ADHD and Other Learning Disabilities, (Huntington House Publishers, Louisiana, 2001), p. 43
“Drug Scheduling,” U.S. Drug Enforcement Administration Online, Internet URL: http://www.dea.gov
Report of the International Narcotics Control Board for 1995, United Nations Publication, ISSN 0257-3717
“Methylphenidate (A Background Paper),” U.S. Drug Enforcement Administration, Oct. 1995, p. 16
Jim Rosack, “Controversy Erupts Over Ads for ADHD Drugs,” Psychiatric News, 2 Nov. 2001
Physicians Desk Reference, 1998, (Medical Economics Company, New Jersey, 199

, pp. 1896-1897
Ibid., p. 1897
Adrainne Jeffries, “Some Teens Abuse ADD/ADHD Drugs,” The Virginian-Pilot, 29 Mar. 2004
Sydney Walker, III, M.D., The Hyperactivity Hoax, (St. Martin’s Press, New York, 199

, p. 47
Paul Wenske, “Small Study Links Ritalin, Cancer Risk,” The Kansas City Star, 17 Mar. 2005
Kathleen Fackelmann, “Health campaign Takes Aim at Prescription Drug Abuse,” USA Today, 10 Apr., 2001; Nicole Ziegler, “Recreational Ritalin,” The Associated Press, 5 May 2000; Christine Langdon, “Tired? Pop your Pal’s Ritalin: Students Using RX Drug as Study Aid,” The New York Post, 28 May 2000; Kelly Trahan, “U. Michigan Study Finds More Adolescents Using Ritalin Recreationally,” Michigan Daily, Mar. 2001; Peter Maller, Laura Lynch-German, “Adults are Becoming Hooked on Ritalin’s Caffeine-Like Jolt,” The Milwaukee Journal Sentinel, 12 Feb. 2001; Paul Zielbauer, New York Times Service, International Herald Tribune, 25 Mar. 2000, p. 3
DEA 1996 report, p. 29
Nadine Lambert, “Stimulant Treatment as a Risk Factor for Nicotine Use and Substance Abuse,” National Institutes of Health Consensus Conference on Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder, 16-18 Nov. 1998
“A Drug Disaster?” Doctors for Disaster Preparedness Newsletter September 2001 Vol. XVIII, No. 5, citing Journal of Forensic Science, 1999, Vol. 44, pp. 220-221
DEA Congressional Testimony, Statement by Terrance Woodworth, Deputy Director, Office of Diversion Control, before the Committee on Education and the Workforce: Subcommittee on Early Childhood, Youth and Families, 16 May 2000
Kay Lazar, “School Daze - Kid-Drug Ads Spark Concern,” Boston Globe, 2 Sept. 2001
Op. cit. National Institutes of Health Consensus Development Conference Statement, p. 5
Brian Vastig, “Pay Attention: Ritalin Acts Much Like Cocaine,” Journal of the American Medical Association, Aug. 22/29, 2001, Vol. 286, No. 8, p. 905
Dr. Richard Nakamura, Evidence Before the U.S. Government Reform Committee Hearing on the Over Medication of Hyperactive Children, 26 Sept. 2002
“Adderall,” DrugStore.com, Internet URL: http://www.drugstore.com
Brian White, “Slaying blamed on reaction to hyperactivity drug,” Associated Press Wire, 25 Oct. 1999
Gardiner Harris, “Citizens’ Group Wants Hyperactivity Drug Taken Off the Market,” The New York Times, 25 Mar. 2005
“Drug Report,” Quarterly Report, Ontario Medical Association Committee on Drugs and Pharmacotherapy, 1 Dec. 1999
Jim Rosack, “ADHD Treatment Arsenal Increasing Rapidly,” Psychiatric News, 21 Dec. 2001
“Study Suggests Focalin (TM) LA Capsules (d-MPH-ER) Are Safe and Effective for ADHD in Adults,” PR Newswire, 5 May 2004; A.D.D. Warehouse website
“ATTENTION DEFICIT HYPERACTIVITY DISORDER: FDA Approves Sprinkle Administration for Once-Daily ADHD Treatment,” Pain & Central Nervous System Week, 6 May 2002
ADHDHelp, Internet URL: http://www.adhdhelp.org/metadate.htm
Ibid.; Diagnostic and Statistical Manual of Mental Disorders (Third Edition–Revised) DSM-III-R, (American Psychiatric Association, Washington D.C., 1987) pp. 136, 175
Kelly Patricia O’Meara, “Ritalin Could Cause ‘Long-Lasting Changes,’” Insight Magazine, 12 Dec. 2002
“Attention Drug to Get New Warning,” Los Angeles Times, 18 Dec. 2004
“Strattera to Get New Risk Label,” The Washington Post, 18 Dec. 2004
“New Drugs in Pipeline,” Psychiatric News, 21 Dec. 2001
Alice Park, “More Drugs To Treat Hyperactivity,” Time, 10 Sept. 2001
Bupropion Wellbutrin, Prozac Truth website
Ibid.
“Teen Suffers Seizure After Snorting Antidepressant,” HealthScoutNews Reporter, 23 Apr. 2003
Joseph Glenmullen, M.D., Prozac Backlash, (Simon & Schuster, New York, 2000), p. 13
Ibid., p. 203
Ibid.
“Antidepressants Lift Clouds, But Lost ‘Miracle Drug’ Label,” The New York Times, 30 June 2002
Op. cit., Joseph Glenmullen, p. 8
“Worsening Depression and Suicidality in Patients Being Treated with Antidepressant Medications,” US Food and Drug Administration Public Health Advisory, 22 Mar. 2004
Ibid.
“Adverse SSRI Reactions,” International Coalition For Drug Awareness website, Internet URL:
http://www.drugawareness.org; “Medication Profiles: Serotonin Reuptake Blocking Agents (SSRIs),” Anxieties.com website, Internet URL: http://www.anxieties.com; Karen Thomas, USA Today, 14 July 2002
Op. cit., FDA Public Health Advisory, 22 Mar. 2004
Anna Wilde Mathews, “FDA Will Seek to Revise Antidepressant Labels for Youth,” The Wall Street Journal, 20 Aug. 20, 2004; Gardiner Harris, “Antidepressant Study Seen to Back Expert,” The New York Times, 20 Aug. 2004
Ibid.
Labeling Change Request Letter for Antidepressant Medications – FDA Letter, 15 Oct. 2004; “FDA orders strong ‘black box’ warnings on antidepressants used by children,” Associated Press Worldstream, 15 Oct. 2004
Chris Cuomo, “DRUG DANGER COVER-UP? EVIDENCE OF SUPPRESSED INFORMATION,” Prime Time Live, ABC News, 9 Dec. 2004
Jeff Swiatek, “Uncertainty was Driver in Zyprexa Deal,” IndianapolisStar.com, 11 June 2005
“FDA Mulls Antidepressant Warnings,” Daily Press, 21 Mar. 2004
Ibid.
Kevin Lamb, “Increased Fears Over Side Effects Concern Antidepressant Users, Medical Experts,” Cox News, 26 Mar. 2004
Op. cit., Chris Cuomo, Prime Time Live
Robert Whitaker, Mad in America: Bad Science, Bad Medicine, and the Enduring Mistreatment of the Mentally Ill, (Perseus Publishing, New York, 2002), p. 203
Ibid., pp. 253-254; Ty C. Colbert, Rape of the Soul, How the Chemical Imbalance Model of Modern Psychiatry hasFailed its Patients, (Kevco Publishing, California, 2001), p. 106
George Crane, “Tardive Dyskinesia in Patients Treated with Major Neuroleptics: A Review of the Literature,” AmericanJournal of Psychiatry, Vol. 124, Supplement, 1968, pp. 40-47
Op. cit., Robert Whitaker, p. 208
Ibid., p. 286
“Leading Therapy Classes by Global Pharmaceutical Sales, 2003,” IMSHealth.com, 2004
Op. cit., Robert Whitaker, p. 269
Erica Goode, “Leading Drugs for Psychosis Come Under New Scrutiny,” The New York Times, 20 May 2003
Ibid.
Op. cit., Jeff Swiatek, IndianapolisStar.com
Robert Whitaker, “Forced medication is inhumane...,” The Boston Globe, 9 June 2002
“ABILIFY Rx Only (aripiprazole) Tablets,” Package Insert, revised Mar. 2004; “GENERIC NAME: Aripiprazole BRAND NAME: Abilify,” Internet URL: http://www.MedicineNet.com, Last Editorial Review: 9/8/04; “Aripiprazole Brand Name: Abilify,” Internet URL: http://www.HealthyPlace.com, Last updated 3/04
Ibid.
“FDA: Antipsychotic Drugs, Diabetes Linked,” Associated Press Online, 18 Sept. 2003
Op. cit., “ABILIFY Rx Only (aripiprazole) Tablets.”
“The New Anti-Psychotic Drug Aripiprazole (ABILIFY),” Public Citizen’s eLetter, Apr. 2003
Op. Cit., Erica Goode
Op. cit., Sydney Walker, A Dose of Sanity, p. 67
Richard Hughs and Robert Brewin, The Tranquilizing of America (Harcourt Brace Jovanovich, Inc., New York, 1979), p. 15
Schrag and Diane Divoky, The Myth of the Hyperactive Child, (Pantheon Books, New York, 1975), pp. 56-57
Ibid., p. 51
Herb Kutchins, Stuart A. Kirk, Making Us Crazy, (The Free Press, NY, 1997), p. 265
Dave Moniz, “Thousands of Troops Let Go for Psychiatric Troubles,” The Indianapolis Star, 28 Sept. 1999
Op. cit., Dr. Mary Ann Block, p. 84
Raymond M. Lombardi, N.D., D.C., C.C.N., “ADHD, A Modern Malady,” Nutrition Science News, Aug. 2000
Op. cit., Sydney Walker, pp. 73-74
Paul R. McHugh, “How Psychiatry Lost Its Way,” American Jewish Committee Commentary, 1 Dec. 1 1999

28 June 2007, 15:23	#3
Astrada Lid Geregistreerd op: 19 March 2007 Berichten: 82	Chrizzly, dit staat er op marktplaats en is dus een STRUCTUREEL probleem binnen de psychiatrie... http://www.marktplaats.nl/index.php?...tml%3Fxref%3D1 En daar al mijn bronnen bij voorbaat al worden afgekraakt door Chrizzly en hij tevens weigerd ze via links te bekijken zet ik ze maar voor zijn neus neer op dit forum. Dit is éénmalig, als poging om van de herhaaldelijke ontkenningen omtrent mijn bronnen door Chrizzly af te zijn, hoop niet dat het gezien word als forum-vervuiling... 2“Suicidality in Children and Adolescents Being Treated With Antidepressant Medications”, FDA Public Health Advisory, 15 Oct. 04. 3“New Warning for Strattera” FDA Talk Paper, 17 Dec. 04. 4“FDA Issues Public Health Advisory for Antipsychotic Drugs Used for Treatment of Behavioral Disorders in Elderly Patients,” FDA Talk Paper, 11 Apr. 05. 5“European Medicines Agency finalises review of antidepressants in children and adolescents,” European Medicines Agency Press Release, 25 Apr. 05. 6“Statement on Concerta and Methylphenidate”, Statement posted on the FDA website, 28 June 05. 7“Suicidality in Adults Being Treated with Antidepressant Medications,”FDA Public Health Advisory, 30 June 05. 8“Accompanying Statement by Joseph A. Califano, Jr., Cairman ans President”, Under the counter: The Diversion and Abuse of Controlled Prescription Drugs in the U.S, National Center on Addiction and Substance Abuse at Columbia University, July 05, pp.i-iii. 9Joanna Moncrief and Irving Kirsch, “Efficacy of Antidepressants in Adults”, British Medical Journal, Vol.331,16 July 05,pp. 155-157. 10“Accompanying Statement by Joseph A. Califano, Jr., Cairman and President,”National Survey of American Attitudes on Substance Abuse X: Teens and Parents, National Center on Addiction and Substance Abuse at Columbia University, Aug. 05, pp. I-ii. 11“Annex II,” Commission Decision of 19-VIII-2005, Commission of the European Communities, 19 Aug. 05. 12Ivar Aursnes, et al., “Suicide Attempts in Clinical Trials with Paroxetine Randomised Against Placebo”, BMC Medicine, Vol.3,pp. 14-18. 13Marian S. Macdonagh, PharmaD, and Kim Peterson, MS “Drug Class Review on Pharmacologic Treatment for ADHD: Final Report,”Oregon Health and Science University, Sept. 05, pp. 13-20. 14Jeffrey A. Lieberman, MD, et al.,“Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia,” New England Journal of Medicine, Vol.353, No. 12, 22 Sept. 05, pp. 1209-1232. 15Laurent Neergaard, “FDA Commissioner Lester Crawford Resigns,” Associated Press, 23 Sept. 05; Robert Pear and Andrew Pollack, “Leader of the FDA Steps Down After a Short Turbulent Tenure,” New York Times, 24 Sept. 05. 16“Depression in Children and Young People,” National Institute for Health and Clinical Excellence, Sept. 05, pp. 16,18 and 28. 17“Suicidal Thinking in Children and Adolescents Being Treated with Strattera (Atomoxetine),” FDA Public Health Advisory, 29 Sept. 05. 18“Concluding Observations (Australia)”, UN Committee on the Rights of the Child, 40th Session, 30 Sept. 05; “Comcluding Observations (Denmark)”, UN Committee on the Rights of the Child, 40th Session, 30 Sept. 05; “Comcluding Observations (Finland)”, UN Committee on the Rights of the Child, 40th Session, 30 Sept. 05. Jeannie Russell, “The Pill That Teachers Push,” Good Housekeeping, Dec. 1997 “Survey: 1 in 5 Teens Getting High on Medications, Over-Counter Drugs,” NewsItem.com, 2 June 2005 Joyce Howard Price, “Antidepressant Use by Preschoolers Rising,” The Washington Times, 3 Apr. 2004 Jacqueline A. Sparks, Ph.D. & Barry L. Duncan, Psy.D., “The Ethics and Science of Medicating Children,” Center for Family Services, Palm Beach County & Florida Institute for the Study of Therapeutic Change Jennifer Washburn, “Tainted to the Core: Why Conflicts of Interest are Hazardous to Your Health,” Institute for Public Affairs, In These Times, 20 June 2005 Fred Baughman Jr., M.D, “Transcript: Calls for Investigation into Diagnosis of ADHD,” ABC Australia Online, 23 Mar. 2000, Internet URL: http://www.abc.net.au; “The White House on Ritalin,” New York Press, 29 Mar. - 4 Apr. 2000 Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, “Psychopharmacologic Drugs Advisory Committee With the Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee,” Testimony of Dr. Gianna Rigoni from the Office of Drug Safety of the FDA, 2 Feb. 2004 Kate Zernike and Melody Petersen, “Schools’ Backing of Behavior Drugs Comes Under Fire,” The New York Times, 19 Aug. 2001 Karen Thomas, “Back to School for ADHD Drugs,” USA Today, 28 Aug. 2001 “Leading Therapy Classes by Global Pharmaceutical Sales, 2003,” IMSHealth.com, 2004 Op. cit., Karen Thomas Dr. Tana Dineen, Ph.D., Manufacturing Victims, Third Edition, (Robert Davies Multimedia Publishing, Montreal, 2001), p. 86 “Ten Things That Drive Psychiatrists To Distraction,” The Independent, (United Kingdom), 19 Mar. 2001 Sydney Walker, III, M.D., A Dose of Sanity: Mind, Medicine and Misdiagnosis, (John Wiley & Sons, Inc, New York, 1996), p. 5 Thomas S. Szasz, M.D., The Therapeutic State, Psychiatry in the Mirror of Current Events, (Prometheus Books, New York, 1984), p. 32 David Kaiser, M.D., “Commentary: Against Biologic Psychiatry,” Psychiatric Times, Dec. 1996, http://www.mhsource.com/edu/psytimes/p961242.html Bruce D. Levine, Ph.D., Commonsense Rebellion: Debunking Psychiatry, Confronting Society, (Continuum, New York, 2001), p. 277 Elliot S. Valenstein, Ph.D., Blaming the Brain, (The Free Press, New York, 199, p. 4 Joseph Glenmullen, M.D., Prozac Backlash, (Simon & Schuster, NY, 2000), pp. 193, 196 Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder, National Institutes of Health Consensus Statement Online, 16-18 Nov. 1998 “Anatomical MRI of the Developing Human Brain: What Have We Learned? Magnetic resonance imaging; Statistical Data Included. Journal of the American Academy of Child and Adolescent Psychiatry, 1 Sept. 2001 Lisa M. Krieger, “Some Question Value of Brain Scan; Untested Tool Belongs in Lab Only, Experts Say,” The MercuryNews, 4 May 2004 Ibid. Ibid. Kelly Patricia O’Meara, “In ADHD Studies, Pictures May Lie,” Insight on the News, 19 Aug, 2003 Elliot S. Valenstein, Ph.D., Blaming the Brain (The Free Press, New York, 199, p. 126 Ibid. Dr. Mary Ann Block, No More ADHD, (Block Books, Texas, 2001), p.30 “National Institutes of Health Consensus Development Conference: Diagnosis and Treatment of Attention- Deficit/Hyperactivity Disorder,” Journal of the American Academy of Child and Adolescent Psychiatry, No. 2, Vol. 39, p. 182; Op. cit., Dr. Mary Ann Block, p. 53 Jan Strydom, Susan du Plessis, The Myth of ADHD and Other Learning Disabilities, (Huntington House Publishers, Louisiana, 2001), p. 43 “Drug Scheduling,” U.S. Drug Enforcement Administration Online, Internet URL: http://www.dea.gov Report of the International Narcotics Control Board for 1995, United Nations Publication, ISSN 0257-3717 “Methylphenidate (A Background Paper),” U.S. Drug Enforcement Administration, Oct. 1995, p. 16 Jim Rosack, “Controversy Erupts Over Ads for ADHD Drugs,” Psychiatric News, 2 Nov. 2001 Physicians Desk Reference, 1998, (Medical Economics Company, New Jersey, 199, pp. 1896-1897 Ibid., p. 1897 Adrainne Jeffries, “Some Teens Abuse ADD/ADHD Drugs,” The Virginian-Pilot, 29 Mar. 2004 Sydney Walker, III, M.D., The Hyperactivity Hoax, (St. Martin’s Press, New York, 199, p. 47 Paul Wenske, “Small Study Links Ritalin, Cancer Risk,” The Kansas City Star, 17 Mar. 2005 Kathleen Fackelmann, “Health campaign Takes Aim at Prescription Drug Abuse,” USA Today, 10 Apr., 2001; Nicole Ziegler, “Recreational Ritalin,” The Associated Press, 5 May 2000; Christine Langdon, “Tired? Pop your Pal’s Ritalin: Students Using RX Drug as Study Aid,” The New York Post, 28 May 2000; Kelly Trahan, “U. Michigan Study Finds More Adolescents Using Ritalin Recreationally,” Michigan Daily, Mar. 2001; Peter Maller, Laura Lynch-German, “Adults are Becoming Hooked on Ritalin’s Caffeine-Like Jolt,” The Milwaukee Journal Sentinel, 12 Feb. 2001; Paul Zielbauer, New York Times Service, International Herald Tribune, 25 Mar. 2000, p. 3 DEA 1996 report, p. 29 Nadine Lambert, “Stimulant Treatment as a Risk Factor for Nicotine Use and Substance Abuse,” National Institutes of Health Consensus Conference on Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder, 16-18 Nov. 1998 “A Drug Disaster?” Doctors for Disaster Preparedness Newsletter September 2001 Vol. XVIII, No. 5, citing Journal of Forensic Science, 1999, Vol. 44, pp. 220-221 DEA Congressional Testimony, Statement by Terrance Woodworth, Deputy Director, Office of Diversion Control, before the Committee on Education and the Workforce: Subcommittee on Early Childhood, Youth and Families, 16 May 2000 Kay Lazar, “School Daze - Kid-Drug Ads Spark Concern,” Boston Globe, 2 Sept. 2001 Op. cit. National Institutes of Health Consensus Development Conference Statement, p. 5 Brian Vastig, “Pay Attention: Ritalin Acts Much Like Cocaine,” Journal of the American Medical Association, Aug. 22/29, 2001, Vol. 286, No. 8, p. 905 Dr. Richard Nakamura, Evidence Before the U.S. Government Reform Committee Hearing on the Over Medication of Hyperactive Children, 26 Sept. 2002 “Adderall,” DrugStore.com, Internet URL: http://www.drugstore.com Brian White, “Slaying blamed on reaction to hyperactivity drug,” Associated Press Wire, 25 Oct. 1999 Gardiner Harris, “Citizens’ Group Wants Hyperactivity Drug Taken Off the Market,” The New York Times, 25 Mar. 2005 “Drug Report,” Quarterly Report, Ontario Medical Association Committee on Drugs and Pharmacotherapy, 1 Dec. 1999 Jim Rosack, “ADHD Treatment Arsenal Increasing Rapidly,” Psychiatric News, 21 Dec. 2001 “Study Suggests Focalin (TM) LA Capsules (d-MPH-ER) Are Safe and Effective for ADHD in Adults,” PR Newswire, 5 May 2004; A.D.D. Warehouse website “ATTENTION DEFICIT HYPERACTIVITY DISORDER: FDA Approves Sprinkle Administration for Once-Daily ADHD Treatment,” Pain & Central Nervous System Week, 6 May 2002 ADHDHelp, Internet URL: http://www.adhdhelp.org/metadate.htm Ibid.; Diagnostic and Statistical Manual of Mental Disorders (Third Edition–Revised) DSM-III-R, (American Psychiatric Association, Washington D.C., 1987) pp. 136, 175 Kelly Patricia O’Meara, “Ritalin Could Cause ‘Long-Lasting Changes,’” Insight Magazine, 12 Dec. 2002 “Attention Drug to Get New Warning,” Los Angeles Times, 18 Dec. 2004 “Strattera to Get New Risk Label,” The Washington Post, 18 Dec. 2004 “New Drugs in Pipeline,” Psychiatric News, 21 Dec. 2001 Alice Park, “More Drugs To Treat Hyperactivity,” Time, 10 Sept. 2001 Bupropion Wellbutrin, Prozac Truth website Ibid. “Teen Suffers Seizure After Snorting Antidepressant,” HealthScoutNews Reporter, 23 Apr. 2003 Joseph Glenmullen, M.D., Prozac Backlash, (Simon & Schuster, New York, 2000), p. 13 Ibid., p. 203 Ibid. “Antidepressants Lift Clouds, But Lost ‘Miracle Drug’ Label,” The New York Times, 30 June 2002 Op. cit., Joseph Glenmullen, p. 8 “Worsening Depression and Suicidality in Patients Being Treated with Antidepressant Medications,” US Food and Drug Administration Public Health Advisory, 22 Mar. 2004 Ibid. “Adverse SSRI Reactions,” International Coalition For Drug Awareness website, Internet URL: http://www.drugawareness.org; “Medication Profiles: Serotonin Reuptake Blocking Agents (SSRIs),” Anxieties.com website, Internet URL: http://www.anxieties.com; Karen Thomas, USA Today, 14 July 2002 Op. cit., FDA Public Health Advisory, 22 Mar. 2004 Anna Wilde Mathews, “FDA Will Seek to Revise Antidepressant Labels for Youth,” The Wall Street Journal, 20 Aug. 20, 2004; Gardiner Harris, “Antidepressant Study Seen to Back Expert,” The New York Times, 20 Aug. 2004 Ibid. Labeling Change Request Letter for Antidepressant Medications – FDA Letter, 15 Oct. 2004; “FDA orders strong ‘black box’ warnings on antidepressants used by children,” Associated Press Worldstream, 15 Oct. 2004 Chris Cuomo, “DRUG DANGER COVER-UP? EVIDENCE OF SUPPRESSED INFORMATION,” Prime Time Live, ABC News, 9 Dec. 2004 Jeff Swiatek, “Uncertainty was Driver in Zyprexa Deal,” IndianapolisStar.com, 11 June 2005 “FDA Mulls Antidepressant Warnings,” Daily Press, 21 Mar. 2004 Ibid. Kevin Lamb, “Increased Fears Over Side Effects Concern Antidepressant Users, Medical Experts,” Cox News, 26 Mar. 2004 Op. cit., Chris Cuomo, Prime Time Live Robert Whitaker, Mad in America: Bad Science, Bad Medicine, and the Enduring Mistreatment of the Mentally Ill, (Perseus Publishing, New York, 2002), p. 203 Ibid., pp. 253-254; Ty C. Colbert, Rape of the Soul, How the Chemical Imbalance Model of Modern Psychiatry hasFailed its Patients, (Kevco Publishing, California, 2001), p. 106 George Crane, “Tardive Dyskinesia in Patients Treated with Major Neuroleptics: A Review of the Literature,” AmericanJournal of Psychiatry, Vol. 124, Supplement, 1968, pp. 40-47 Op. cit., Robert Whitaker, p. 208 Ibid., p. 286 “Leading Therapy Classes by Global Pharmaceutical Sales, 2003,” IMSHealth.com, 2004 Op. cit., Robert Whitaker, p. 269 Erica Goode, “Leading Drugs for Psychosis Come Under New Scrutiny,” The New York Times, 20 May 2003 Ibid. Op. cit., Jeff Swiatek, IndianapolisStar.com Robert Whitaker, “Forced medication is inhumane...,” The Boston Globe, 9 June 2002 “ABILIFY Rx Only (aripiprazole) Tablets,” Package Insert, revised Mar. 2004; “GENERIC NAME: Aripiprazole BRAND NAME: Abilify,” Internet URL: http://www.MedicineNet.com, Last Editorial Review: 9/8/04; “Aripiprazole Brand Name: Abilify,” Internet URL: http://www.HealthyPlace.com, Last updated 3/04 Ibid. “FDA: Antipsychotic Drugs, Diabetes Linked,” Associated Press Online, 18 Sept. 2003 Op. cit., “ABILIFY Rx Only (aripiprazole) Tablets.” “The New Anti-Psychotic Drug Aripiprazole (ABILIFY),” Public Citizen’s eLetter, Apr. 2003 Op. Cit., Erica Goode Op. cit., Sydney Walker, A Dose of Sanity, p. 67 Richard Hughs and Robert Brewin, The Tranquilizing of America (Harcourt Brace Jovanovich, Inc., New York, 1979), p. 15 Schrag and Diane Divoky, The Myth of the Hyperactive Child, (Pantheon Books, New York, 1975), pp. 56-57 Ibid., p. 51 Herb Kutchins, Stuart A. Kirk, Making Us Crazy, (The Free Press, NY, 1997), p. 265 Dave Moniz, “Thousands of Troops Let Go for Psychiatric Troubles,” The Indianapolis Star, 28 Sept. 1999 Op. cit., Dr. Mary Ann Block, p. 84 Raymond M. Lombardi, N.D., D.C., C.C.N., “ADHD, A Modern Malady,” Nutrition Science News, Aug. 2000 Op. cit., Sydney Walker, pp. 73-74 Paul R. McHugh, “How Psychiatry Lost Its Way,” American Jewish Committee Commentary, 1 Dec. 1 1999